References
- Rousseau M, Guillotel B. Risk factors for deep venous thrombosis in tetraparesic mentally retarded patients. Brain Injury 2001;15:1041–44.
- Hull R. Peripheral venous disease. In: Goldman L, Ausiello D, editors. Cecil textbook of medicine, 22nd ed. Philadelphia, PA: Saunders; 2004. pp. 472–88.
- Taubman L, Silverstone F. Autopsy proven pulmonary embolism among the institutionalized elderly. Journal of the American Geriatric Society 1986;34:752–6.
- Gunduz S, Ogur E, Mohur H. Deep vein thrombosis in spinal cord injured patients. Paraplegia 1993;31: 606–10.
- Heit J, Ofallon W, Petterson T, Lohse C. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism. Archives of Internal Medicine 2002;162:1245–8.
- Bloemenkamp K, Helmerhorst F, Rosendaal F. Thrombophilias and gynecology. Best Practice Research in Clinical Obstetric Gynecology 2003;17:509–28.
- Steiner M, Hodes M, Shreve M, Sundberg S, Edson J. Postoperative stroke in a child with cerebral palsy heterozygous for factor V Leiden. Journal of Pediatric Hematology and Oncology 2000;22:262–4.
- Homans J. Thrombosis of the deep leg veins due to prolonged sitting. New England Journal of Medicine 1954;250:148–9.
- Simpson K. Shelter deaths from pulmonary embolism. Lancet 1940;2:744.
- Hughes R, Hopkins R, Hill S. Frequency of venous thromboembolism in low to moderate risk long distance air travelers. Lancet 2003;362:2039–44.
- Jordan W. Pulmonary embolism. Lancet 1961;1:1146.
- Sidelman J, Jespersen J, Andersen L, Slouby S. Hormone replacement therapy and hypercoagulability. British Journal of Obstetrics & Gynecology 2003;110:541–7.
- Lidegaard O, Edstrom B, Kreiner S. Oral contraceptives and venous thromboembolism. Contraception 1998;57:291–301.
- Rosendaal F, Van H, Tanis B. Estrogens, progestogens and thrombosis. Journal of Thrombosis and Hemostasis 2003;7:1371–80.
- Kastrup E. Sex hormones. Drug facts & comparisons. St Louis, MO: Walters Kluwer Health; 2004. pp. 217–69.
- Scarabin P, Oger E, Plu-Bureau G. Differential association of oral and transdermal estrogen replacement therapy with venous thromboembolism risk. Lancet 2003;362:428–32.
- Cushman M. Quoted by Brunk D. Estrogen plus progestin doubles thrombosis risk. Family Practice News; 15 January 2004.
- Boen J, Andersen R, Bennett R. Deep vein thrombosis as a complication of magesterol acetate therapy in nursing home residents. Journal of the American Medical Directors Association 2000;1:248–52.
- Wells P, Anderson D, Rodger M. Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the model's utility with the simlired D dimer. Thrombisis and Hemostasis 2000;83:416–20.
- Smucny J, Cohanim R. What clinical findings can be used to diagnose deep venous thrombosis. American Family Physician 2004;70:565–6.
- Moerloose P. Performance of the Vidas D dimer assay for the exclusion of venous thromboembolism. Thrombosis and Hemostasis 2001;85:185–6.
- Gabella G. Veins of the lower limbs. In: Williams P, Bannister L, Berry M, Collins P, editors. Gray's anatomy, 38th ed. Philadelphia, PA: Churchill Livingstone; 1995. pp. 1595–8.
- Dahnert W. Cardiovascular anatomy. In: Radiology review manual, 5th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2003. p 601.
- Hirsch J. Antithrombotic therapy. In: Goldman L, Ausiello D, editors. Cecil textbook of medicine, 22nd ed. Philadelphia, PA: Saunders; 2004. pp. 161–70.